( MENAFN - EIN Presswire) Insomnia market Report Insomnia companies are Vanda Pharmaceuticals, Janssen Pharmaceutical, Taisho Pharmaceutical, Neurim Pharmaceuticals, Imbrium Therapeutics, and others. LAS VEGAS, NEVADA, UNITED STATES, June 9, 2024 /EINPresswire / -- DelveInsight's“Insomnia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Insomnia, historical and forecasted epidemiology as well as the Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Insomnia Market Forecast Some of the key facts of the Insomnia Market Report: The Insomnia market size is anticipated to grow with a significant CAGR during the study period (2019-2032).
The Insomnia market size in the 7MM was approximately USD 5,700 million in 2022 and is projected to increase during the forecast period (2023–2032). The Insomnia diagnosed prevalence has been increasing due to the increasing prevalence of lifestyle-associated disorders, besides increasing population and awareness of sleep disorders. Increased awareness and a better understanding of disease pathophysiology have improved diagnosis and treatment.
Benzodiazepines and benzodiazepine receptor antagonists, so-called Z-drugs, are widely used first-line pharmacotherapy to decrease sleep latency and are approved for.